HOW HAS PANDEMIC AFFECTED CLINICAL RESEARCH INDUSTRY
Tags: clinicalresearchcourses, clinicalresearchtraining, pharmacovigilancetraining, clinicalresearch
Published: 2021-09-03 07:15:17


SUMMARY: The current COVID-19 pandemic is affecting clinical research activities in most parts of the world. The focus on developing a vaccine for the treatment of COVID-19 is, in fact, disrupting many upcoming and/or ongoing clinical trials on other diseases around the globe. Due to the sudden onset and wide-spread impact of COVID-19, its influence on the management of clinical trials and research necessitates urgent attention. The pandemic has placed a tremendous strain on the clinical research enterprises and clinical research courses. With the redirection of resources and temporary halting of in-person visits, studies in other therapeutic areas have been unavoidably constrained. However, the COVID-19 response has also introduced innovations that have advanced our overall conduct of clinical research.
 
The following article aims to introduce the new Global trends in Clinical Research due to the Pandemic.  
Covid-19 had a huge impact on the way clinical trials are managed and conducted in India and globally due to the urgent medical needs arising from a pandemic that was of mammoth proportion. New trends that have been introduced in clinical research due to the Pandemic are as follows:

•	Global decentralized clinical trials
2020 was a transformative year for the way trials are being conducted and 2021 is taking this even further. Decentralized trials which became a necessity during the multiple 2020 lockdowns are not only a way to ensure your trial can continue even in a situation of global crisis but also a way to diversify study participants who have taken up clinical courses and attend to the needs of patients in trials. 
Virtual technologies and remote care will continue to support trials affected by the Covid-19 crisis. The decentralized approach will be considered more and more in the planning of new studies, courses and careers as well. The more trials go virtual/hybrid/remote – the more data will be available to make feasibility for decentralized trials a more familiar endeavour. From predicting average recruitment rates to partnering with already experienced investigators, data is needed to make this big shift, especially considering the monetary cost of remote trials. 
•	Addressing Data Hurdles
Speaking of data, clinical trials stand to hugely benefit from optimizing their data collection and storage processes. 2020 revealed the need for unblocking common bottlenecks in clinical research one of which is the way data is being stored and accessed. 
The massive data sets that life science companies rely on in the process of drug development need to be made easier to organize and access. Drug development cannot be optimized without addressing the storage of and access to the massive amount of data the industry produces. 
Just as an example (although the issue with data spans wider than this) public clinical trial registers suffer from a chronic lack of systematic, regular updates. As a result, they are not only difficult to use by patients and industry professionals alike but also misleading. The planning stages of any research study rely on accurate and accessible information. 
•	Digital therapeutics will accompany drugs
Another aspect of digitalization that 2020 brought about and will continue to grow in importance is digitally collecting data from patients not only in but also outside of trials. And we’re not talking about patient reported outcomes although these are important as well. 
Digital therapeutics such as wearables that monitor important indicators 24/7 will start being prescribed alongside drugs as part of more holistic treatment. What this means for clinical research training is that real-world data will be potentially made easier to collect and access. 
It has been roughly a year since the Coronavirus hit and much has been written about the disruptive effects it has had on our lives. It has upended many practices that were hitherto considered to be the norm; from spawning remote-working trends to accelerating digital transformation across sectors. As the focus shifted to research and development of new drugs and vaccines to treat and prevent Covid-19, clinical trials received heightened attention and scrutiny. Covid-19 and the lockdowns that followed spelled change for the way trials are being conducted and the most notable one is in the way data is and will be collected, stored and accessed.
https://www.clariwell.in/best-clinical-research-courses-in-pune-with-100-percent-job-guarantee